0
Prescription Medicine
₹17934
₹2690.0Cashback (15%)(Inclusive of all Taxes)
Offers & DiscountsGet Free delivery (₹99) with
Leuxa Depot 22.5 mg Injection 1's belongs to the class of synthetic hormones used in the treatment of prostate cancer in men, endometriosis, and hormone-responsive breast cancer in women. Also, Leuxa Depot 22.5 mg Injection 1's is used to treat premature puberty in children. Prostate cancer is cancer of the prostate gland (a small gland under the bladder that produces semen) found only in men. The symptoms include difficulty in urination, pain, numbness, or sexual problems.
Leuxa Depot 22.5 mg Injection 1's contains Leuprorelin, a synthetic hormone that works similarly to the natural hormone, gonadotropin-releasing hormone (GnRH), by acting on the pituitary gland and decreasing the levels of testosterone in men and estrogen in women. Thereby, Leuxa Depot 22.5 mg Injection 1's is used in the treatment of prostate cancer by inhibiting the growth of the tumor or causing it to shrink.
Use Leuxa Depot 22.5 mg Injection 1's as prescribed by your doctor. You are advised to take Leuxa Depot 22.5 mg Injection 1's for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience pain, redness, swelling, or skin hardening at the injection site, muscle weakness, bone pain, inability to have an erection, breast tenderness, headache, vaginal dryness, changes in breast size, acne, or mood swings. Most of these side effects of Leuxa Depot 22.5 mg Injection 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Leuxa Depot 22.5 mg Injection 1's or any other medicines, please tell your doctor. Leuxa Depot 22.5 mg Injection 1's is contraindicated in pregnant and breastfeeding women. It is advised to use effective contraceptive measures to avoid pregnancy while taking Leuxa Depot 22.5 mg Injection 1's as it may cause birth defects. Leuxa Depot 22.5 mg Injection 1's should be used with caution in children. You are recommended to avoid or limit consumption of alcohol with Leuxa Depot 22.5 mg Injection 1's as it may increase the risk of bone density loss. Drive only if you are alert as Leuxa Depot 22.5 mg Injection 1's may cause dizziness, drowsiness, or vision disturbances.
Leuxa Depot 22.5 mg Injection 1's is used in the treatment of prostate cancer, breast cancer, endometriosis, and premature puberty. The detailed uses of Leuxa Depot 22.5 mg Injection 1's are as follows:
Leuxa Depot 22.5 mg Injection 1's contains Leuprorelin which works similarly to the natural hormone, gonadotropin-releasing hormone (GnRH), by acting on the pituitary gland and decreasing the levels of testosterone in men and oestrogen in women. Thereby, Leuxa Depot 22.5 mg Injection 1's is used in the treatment of prostate cancer by inhibiting the growth of the tumour or causing it to shrink. Also, Leuxa Depot 22.5 mg Injection 1's is used to treat hormone-responsive breast cancer in pre and postmenopausal women. By reducing testosterone and oestrogen levels, Leuxa Depot 22.5 mg Injection 1's delays the onset of puberty in children.
Caution
Avoid or limit alcohol consumption with Leuxa Depot 22.5 mg Injection 1's as it may increase the risk of bone density loss.
Unsafe
Leuxa Depot 22.5 mg Injection 1's is not recommended for pregnant women as it may cause birth defects. Please consult a doctor if you are pregnant or planning for pregnancy.
Unsafe
Leuxa Depot 22.5 mg Injection 1's is contraindicated in breastfeeding women. Please consult a doctor if you are breastfeeding.
Caution
Leuxa Depot 22.5 mg Injection 1's may cause dizziness, drowsiness or disturbance in the vision. Therefore, avoid driving if you experience any of these symptoms after taking Leuxa Depot 22.5 mg Injection 1's.
Caution
Take Leuxa Depot 22.5 mg Injection 1's with caution, especially if you have a history of Liver diseases/conditions. The dose may be adjusted by your doctor as required.
Caution
Take Leuxa Depot 22.5 mg Injection 1's with caution, especially if you have a history of Kidney diseases/conditions. The dose may be adjusted by your doctor as required.
Caution
Leuxa Depot 22.5 mg Injection 1's should be used for children under the supervision of a paediatric endocrinologist.
Caution
Leuxa Depot 22.5 mg Injection 1's should be administered with caution in patients with heart problems. Therefore, please talk to your doctor before receiving Leuxa Depot 22.5 mg Injection 1's.
Caution
Leuxa Depot 22.5 mg Injection 1's should be administered with caution to elderly patients due to an increased risk of side effects. Please consult your doctor before receiving Leuxa Depot 22.5 mg Injection 1's.
Have a query?
If you are allergic to Leuxa Depot 22.5 mg Injection 1's or any other medicines, please tell your doctor. Leuxa Depot 22.5 mg Injection 1's is contraindicated in pregnant and breastfeeding women. It is advised to use effective non-hormonal contraceptives such as condoms to avoid pregnancy while taking Leuxa Depot 22.5 mg Injection 1's as it may cause birth defects. Leuxa Depot 22.5 mg Injection 1's should be used with caution in children. You are advised to quit smoking as it may increase the risk of prostate cancer. You are recommended to avoid or limit consumption of alcohol with Leuxa Depot 22.5 mg Injection 1's as it may increase the risk of bone density loss. Drive only if you are alert as Leuxa Depot 22.5 mg Injection 1's may cause dizziness, drowsiness or vision disturbances.
Drug-Drug Interaction: Leuxa Depot 22.5 mg Injection 1's may interact with antibiotics (moxifloxacin), heart-related medicines (procainamide, quinidine, sotalol, amiodarone), narcotic analgesics (methadone), antipsychotics (clozapine).
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: If you have abnormal vaginal bleeding, diabetes, osteoporosis (thinning of bones), depression, blood vessel disorder, seizures (fits), mental illness, spinal cord injury, brain tumor or heart disease, inform your doctor before taking Leuxa Depot 22.5 mg Injection 1's.
Login/Sign Up
Login/Sign Up
RXIpca Laboratories Ltd
₹12047.5
(₹12047.5 per unit)
RXBDR Pharmaceuticals Internationals Pvt Ltd
₹13094
(₹13094.0 per unit)
RXZydus Cadila
₹16993
(₹16993.0 per unit)
Leuxa Depot 22.5 mg Injection 1's contains Leuprorelin, a synthetic hormone that works similar to the natural hormone, gonadotropin-releasing hormone (GnRH) by acting on the pituitary gland and decreases the levels of testosterone in men and oestrogen in women. Thereby, Leuxa Depot 22.5 mg Injection 1's is used in the treatment of prostate cancer by inhibiting the growth of tumour or causing it to shrink.
Leuxa Depot 22.5 mg Injection 1's may stop menstrual periods. However, after 7 to 12 weeks of taking the final dose of injection, periods will resume. Please consult a doctor if you have any concerns regarding this.
Leuxa Depot 22.5 mg Injection 1's should be used with caution in diabetic patients as it may increase the risk of high blood sugar levels. Therefore, it is advised to regularly monitor blood sugar levels while taking Leuxa Depot 22.5 mg Injection 1's and inform your doctor if you have diabetes before taking Leuxa Depot 22.5 mg Injection 1's.
Leuxa Depot 22.5 mg Injection 1's may be used to treat endometriosis (tissue lining the uterus known as endometrium grows outside the uterus). Leuxa Depot 22.5 mg Injection 1's reduces oestrogen levels and causes menopause temporarily. Thereby, shrink the tissue outside the uterus or stop its growth.
Leuxa Depot 22.5 mg Injection 1's may decrease bone density, especially when used for the treatment of premature puberty in children. Therefore, regular monitoring of bone density is recommended while taking Leuxa Depot 22.5 mg Injection 1's.
Leuxa Depot 22.5 mg Injection 1's should be used with extreme caution in patients suffering from depression as it may worsen the condition. Therefore, inform your doctor if you have any history of depression before taking Leuxa Depot 22.5 mg Injection 1's.
No, Leuxa Depot 22.5 mg Injection 1's is not a chemotherapy medicine. It is a synthetic hormone which belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists.
Yes, Leuxa Depot 22.5 mg Injection 1's is a hormonal medicine that works by altering reproductive hormones. It is not recommended for use during pregnancy as it can harm the fetus and may lead to abortion. If you are pregnant or planning to become pregnant, please inform your doctor.
The common side effects of Leuxa Depot 22.5 mg Injection 1's are pain, redness, swelling, or skin hardening at the injection site, muscle weakness, bone pain, inability to have an erection, breast tenderness, headache, vaginal dryness, changes in breast size, acne, or mood swings. If any of these side effects persist or worsen, please consult your doctor.
Leuxa Depot 22.5 mg Injection 1's belongs to the class of synthetic hormones used in the treatment of prostate cancer in men, endometriosis, and hormone-responsive breast cancer in women. Also, it is used to treat premature puberty in children.
Disclaimer
